172
Participants
Start Date
February 28, 2025
Primary Completion Date
June 30, 2025
Study Completion Date
December 31, 2025
Cladribine
Given IV
Cytarabine
Given IV
G-CSF
Given SC
Venetoclax
Given PO
Department of Hematology,Nanfang Hospital, Southern Medical University, Guangzhou
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
OTHER
Guangzhou No.12 People's Hospital
OTHER_GOV
Guangzhou Panyu Central Hospital
OTHER
Guangzhou General Hospital of Guangzhou Military Command
OTHER
Guangzhou First People's Hospital
OTHER
Foresea Life Insurance Guangzhou General Hospital
UNKNOWN
Guangdong Second Provincial General Hospital
OTHER
Jiangmen Central Hospital
OTHER
Shantou Central Hospital
OTHER
Maoming People's Hospital
OTHER
First Affiliated Hospital of Guangxi Medical University
OTHER
Hainan General Hospital
OTHER
Dongguan People's Hospital
OTHER_GOV
Tungwah Hospital of Sun Yat-Sen University
UNKNOWN
Shenzhen Hospital of Southern Medical University
OTHER
Central People's Hospital of Zhanjiang
OTHER
ZhuHai Hospital
OTHER
Shenzhen Second People's Hospital
OTHER
Zhongshan People's Hospital, Guangdong, China
OTHER
LiuZhou People's Hospital
OTHER
First People's Hospital of Foshan
OTHER
Southern Medical University, China
OTHER
Affiliated Hospital of Guangdong Medical University
OTHER
Guilin Medical University, China
OTHER
Yuebei People's Hospital
OTHER
Huizhou Municipal Central Hospital
OTHER
Second Affiliated Hospital of Guangzhou Medical University
OTHER
Peking University Shenzhen Hospital
OTHER
Nanfang Hospital, Southern Medical University
OTHER